SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-160727
Filing Date
2024-06-13
Accepted
2024-06-13 16:21:06
Documents
14
Period of Report
2024-06-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d839776d8k.htm   iXBRL 8-K 31252
  Complete submission text file 0001193125-24-160727.txt   213664

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA blacu-20240607.xsd EX-101.SCH 4878
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE blacu-20240607_def.xml EX-101.DEF 15322
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE blacu-20240607_lab.xml EX-101.LAB 26120
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blacu-20240607_pre.xml EX-101.PRE 16486
17 EXTRACTED XBRL INSTANCE DOCUMENT d839776d8k_htm.xml XML 9115
Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Filer) CIK: 0001840425 (see all company filings)

IRS No.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41390 | Film No.: 241041507
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)